BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING.

Size: px
Start display at page:

Download "BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING."

Transcription

1 BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING. The Inheritest SM Carrier Screen provides relevant genetic screening for many inherited diseases found throughout the pan-ethnic US population.

2 Broaden your patient s options with Inheritest SM Carrier Screen In addition to our comprehensive menu of single gene carrier screening tests, we can now offer you and your patients the option of the Inheritest Carrier Screen to help support your practice needs. For situations where it is difficult to assign a single ethnicity to a patient and you recommend broader carrier screening, the Inheritest Carrier Screen provides genetic information regarding greater than 90 autosomal recessive inherited diseases found throughout the pan-ethnic US population. Inheritest Carrier Screen Provides: Mutation analysis of over 430 common mutations found in 87 different genes, associated with greater than 90 different inherited diseases, providing you with carrier status information for these disease-causing mutations New array platform allowing for many diseases to be evaluated in one test Succinct and informative summary reports, providing details about any positive result up front for easy review Two specimen options available: blood and saliva

3 Empower Your Patients Many patients may not be aware of their genetic family history or carrier status for an autosomal recessive disease prior to having a child affected with the disease. In those clinical situations, providing broader testing options to your patients can empower them with information regarding current, and/or future pregnancies. Knowing their carrier status and risk for having an affected child can allow them to consider the full range of options available to them, which may include: Prenatal or diagnostic testing options such as amniocentesis or CVS, which could help determine whether or not the fetus has inherited the disease-causing mutations In vitro fertilization which could include testing the embryos using pre-implantation genetic diagnosis (PGD) Additional family planning options Expect More from Your Genetics Testing Partner Through the extensive network of services provided by Integrated Genetics and LabCorp, we offer you and your patients a broad array of services, individual tests and profiles. ADDITIONAL TESTING OPTIONS In addition to offering the Inheritest and Inheritest Select Carrier Screens, Integrated Genetics offers other carrier screening options for diseases found in similar frequencies in the general population and for which ACOG and/or ACMG have provided guidelines for when screening may be appropriate. 1-5 Spinal Muscular Atrophy The most common inherited cause of early childhood mortality Fragile X syndrome The leading cause of inherited mental retardation Full hemoglobinopathy screening, utilizing a CBC and hemoelectrophoresis assay If both members of a couple are found to be carriers of the same disease causing gene, Integrated Genetics has a unique ability to perform prenatal testing on amniotic fluid and CVS for any diseases included in our Inheritest Carrier Screen. This fetal testing will be performed as targeted sequencing of only the identified mutations that the parents carry.

4 GENETIC COUNSELING Our trusted genetic counseling services are now available remotely to patients with positive Inheritest Carrier Screen results through the Telegenetic Counseling to You program. Available to patients through telephone or tele-video, the Telegenetic Counseling to You program will include: An explanation of the Inheritest Carrier Screen results to patients Evaluation of other genetic risks to the pregnancy or intended pregnancy based on family history provided by the patient to the genetic counselor A review of appropriate follow-up testing options with patients, if applicable based on the genetic risk assessment performed by the genetic counselor A genetic counseling report for the referring physician, summarizing the genetic risks identified and testing options discussed during the counseling session Patients with positive Inheritest Carrier Screen results referred by their physicians for genetic counseling can call (855)GC-CALLS ( ) to schedule an appointment. ADDITIONAL SUPPORT SERVICES All test results and interpretations are reviewed by our board certified Clinical Molecular Geneticists, providing you with added confidence in the results Extensive network of Patient Service Centers, allowing for easy sample collection Multiple online and electronic ordering and resulting capabilities, providing your office with easy solutions Knowledgeable client services team to help answer any questions about your testing Integrated Genetics (800)

5 Experience You Can Trust Trust in the experience of our board-certified Molecular Geneticists. The same genetics experts at Integrated Genetics and LabCorp reviewed the more common inherited diseases found within the pan-ethnic US population to deliver a broad carrier screening option relevant to the general population. In addition, the Inheritest Select Carrier Screen is also available, providing a test that evaluates a smaller panel of diseases for patients of Ashkenazi Jewish descent. These options may minimize your need for multiple ethnic-based testing scenarios. The Inheritest Carrier Screen includes: Adenosine Deaminase Deficiency Alpha-Mannosidosis Andermann Syndrome Argininosuccinic Aciduria Aspartylglucosaminuria Ataxia-Telangiectasia Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS) Bardet Biedl Syndrome, BSS1-related Bardet Biedl Syndrome, BSS10-related Beta Hemoglobinopathies, Hemoglobins C,D,E,O Beta Thalassemia Bloom Syndrome* Canavan Disease* Cartilage-Hair Hypoplasia Citrullinemia Type I Cobalamin C Disease (Methlymalonic Aciduria with Homocystinuria) Congenital Disorder of Glycosylation Type 1a Cystic Fibrosis* Cystinosis D-Bifunctional Protein Deficiency Dihydrolipoamide Dehydrogenase Deficiency* Dihydropyrimidine Dehydrogenase Deficiency Ethylmalonic Encephalopathy Familial Dysautonomia* Familial Hyperinsulinism, ABCC8-related* Familial Mediterranean Fever Fanconi Anemia Group C* Galactosemia, GALT-related Gaucher Disease* Glutaric Acidemia Type I Glutathione Synthetase Deficiency Glycine Encephalopathy, GLDC-related Glycogen Storage Disease Type Ia* Glycogen Storage Disease Type Ib Glycogen Storage Disease Types IIIa and IIIb GRACILE Syndrome Hereditary Fructose Intolerance HMG-CoA Lyase Deficiency Holocarboxylase Synthetase Deficiency Homocystinuria, CBS-related Joubert Syndrome 2* Junctional Epidermolysis Bullosa, LAMA3-related Junctional Epidermolysis Bullosa, LAMB3-related Junctional Epidermolysis Bullosa, LAMC2-related Krabbe Disease Leigh Syndrome, French-Canadian Type Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD) Maple Syrup Urine Disease Type 1a* Maple Syrup Urine Disease Type 1b* Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD) Metachromatic Leukodystrophy Methylmalonic Acidemia, MMAA-related Methylmalonic Acidemia, MMAB-related Methylmalonic Acidemia, MUT-related Mucolipidosis Type IV* Mucopolysaccharidosis Type I Nemaline Myopathy, NEB-related* Nephrotic Syndrome, NPHS1-related Nephrotic Syndrome, NPHS2-related Neuronal Ceroid-Lipofuscinosis, CLN3-related Neuronal Ceroid-Lipofuscinosis, CLN5-related Neuronal Ceroid-Lipofuscinosis, CLN8-related Neuronal Ceroid-Lipofuscinosis, PPT1-related Neuronal Ceroid-Lipofuscinosis, TPP1-related Niemann-Pick Type A* Niemann-Pick Type B* Niemann-Pick Type C, NPC1-related Niemann-Pick Type C, NPC2-related Nijmegen Breakage Syndrome Phenylalanine Hydroxylase Deficiency (includes PKU) Polycystic Kidney Disease, Autosomal Recessive Pompe Disease Primary Hyperoxaluria Type 1 Primary Hyperoxaluria Type 2 Propionic Acidemia, PCCA-related Propionic Acidemia, PCCB-related Rhizomelic Chondrodysplasia Punctata Type 1 Salla Disease Sandhoff Disease Sickle Cell Disease Sjogren-Larsson Syndrome Smith-Lemli-Opitz Syndrome Sulfate Transporter-Related Osteochondrodysplasias Achondrogenesis Type 1B Atelosteogenesis Type 2 Diastrophic Dysplasia Recessive Multiple Epiphyseal Dysplasia Tay-Sachs Disease* Tyrosinemia Type 1 Usher Syndrome Type IF* Usher Syndrome Type III* Walker-Warburg Syndrome, FKTN-related* Wilson Disease Zellweger Syndrome Spectrum, PEX1-related Zellweger Syndrome Neonatal Adrenoleukodystrophy Infantile Refsum Disease *Included on the Inheritest Select Carrier Screen.

6 Your One Resource for Genetic Testing ALLOW INTEGRATED GENETICS TO BE YOUR COMPLETE RESOURCE FOR GENETIC TESTING Experience You Can Trust Offering over 25 years of genetic testing expertise from board certified Molecular Geneticists Broad Test Offerings Inheritest Carrier Screen, provides information regarding greater than 90 inherited diseases Inheritest Select Carrier Screen provides an additional option for patients of Ashkenazi Jewish descent Follow-up fetal testing for at-risk pregnancies Comprehensive Service Offerings Largest commercial genetic counseling network in the country Extensive Patient Service Center network REFERENCES: 1) Spinal Muscular Atrophy. ACOG Committee Opinion Number 432. May ) Prior, T. Carrier screening for spinal muscular atrophy. ACMG Practice Guidelines. Genet Med 2008; 10(11): ) Sherman, S, et al. Fragile X syndrome: Diagnostic and carrier testing. ACMG Practice Guideline. Genet Med 2005; 7(8): ) Carrier Screening for Fragile X Syndrome. ACOG Committee Opinion Number 469. October ) Hemoglobinopathies in Pregnancy. ACOG Practice Bulletin, Number 78, January Integrated Genetics Client Services (800) Inheritest SM is a service mark of Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings. All rights reserved. L rep-599-v

CHRONIC MYELOGENOUS LEUKEMIA

CHRONIC MYELOGENOUS LEUKEMIA CHRONIC MYELOGENOUS LEUKEMIA SHUFFLING THE GENETIC DECK IN CML 9 9 (q+) 22 Ph (22q-) bcr bcr-abl abl Fusion protein causes cancer GLEEVEC AND BCR-ABL FUSION PROTEIN GENETIC MEDICINE A. Genetic diseases

More information

All diseases on Foresight

All diseases on Foresight All diseases on Foresight Disease 11-Beta-Hydroxylase- Deficient Congenital Adrenal Hyperplasia 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 3-Hydroxy-3-Methylglutaryl- CoA Lyase Deficiency

More information

PATIENT EDUCATION. carrier screening INFORMATION

PATIENT EDUCATION. carrier screening INFORMATION PATIENT EDUCATION carrier screening INFORMATION carrier screening AT A GLANCE Why is carrier screening recommended? Carrier screening is one of many tests that can help provide information to you and your

More information

Foresight Carrier Screen

Foresight Carrier Screen 4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 09/20/2017 Date Received: 09/22/2017 Date Tested: 09/27/2017 Indication:

More information

23andMe Reports GENETIC HEALTH RISK REPORTS. Increased risk for breast and ovarian cancer. function

23andMe Reports GENETIC HEALTH RISK REPORTS. Increased risk for breast and ovarian cancer. function 1 23andMe Reports GENETIC HEALTH RISK REPORTS BRCA1/BRCA2 Late-Onset Alzheimer's Disease Parkinson's Disease Age-Related Macular Degeneration Alpha-1 Antitrypsin Deficiency Celiac Disease G6PD Deficiency

More information

Foresight Carrier Screen

Foresight Carrier Screen 4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 08/17/2017 Date Received: 08/18/2017 Date Tested: 08/24/2017 Indication:

More information

NutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions:

NutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions: NutraHacker Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d Instructions: In this report, NutraHacker examines single nucleotide polymorphisms that reveal carrier status

More information

A Lawyer s Perspective on Genetic Screening Performed by Cryobanks

A Lawyer s Perspective on Genetic Screening Performed by Cryobanks A Lawyer s Perspective on Genetic Screening Performed by Cryobanks As a lawyer practicing in the area of sperm bank litigation, I have, unfortunately, represented too many couples that conceived a child

More information

Foresight Carrier Screen

Foresight Carrier Screen 4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: Date Received: 02/19/2018 Date Tested: 02/26/2018 Accession ID: CSL3P6DMJ324JJ4

More information

Foresight Carrier Screen

Foresight Carrier Screen 321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: OG-510 Saliva Date of Collection: 07/12/2017 Date Received: 07/17/2017 Date Tested: 07/17/2017 Indication:

More information

CLINICAL AND HUMAN TESTING

CLINICAL AND HUMAN TESTING CLINICAL AND HUMAN TESTING CARRIER SCREENING FOR FAMILY PLANNING Let knowledge be your guide. Identify genetic conditions before or during a pregnancy to help predict the chances of having a child with

More information

Foresight Carrier Screen

Foresight Carrier Screen 321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: OG-510 Saliva Date of Collection: 06/23/2017 Date Received: 06/28/2017 Date Tested: 06/28/2017 Indication:

More information

Foresight Carrier Screen

Foresight Carrier Screen 321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: EDTA Blood Date of Collection: 07/12/2017 Date Received: 07/17/2017 Date Tested: 07/17/2017 Indication:

More information

Genetic Testing FOR DISEASES OF INCREASED FREQUENCY IN THE ASHKENAZI JEWISH POPULATION

Genetic Testing FOR DISEASES OF INCREASED FREQUENCY IN THE ASHKENAZI JEWISH POPULATION Carrier Screening and Diagnostic Testing for the Ashkenazi Jewish Population Genetic Testing FOR DISEASES OF INCREASED FREQUENCY IN THE ASHKENAZI JEWISH POPULATION Our Science. Your Care. An extensive

More information

The Israeli population carrier screening program. Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem

The Israeli population carrier screening program. Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem The Israeli population carrier screening program Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem The Israeli population 2015 8,134,500 inhabitants Jews (75.1%) Ashkenazi, non

More information

23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert

23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert Table of contents Intended Use Important warnings and limitations Test performance User studies Specific test information 23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert For in-vitro

More information

Foresight Carrier Screen

Foresight Carrier Screen Freiburg Medical Laboratory, ME LLC Box 3068 Dubai, 00000 Phone: +971 4 396 2227 FE Sample Type: EDTA Blood Date of Collection: 04/23/2018 Date Received: 04/27/2018 Date Tested: 05/05/2018 Indication:

More information

CarrierMap. Genetic Counseling. Technology TABLE OF. Sample Report CONTENTS. New Offerings. Recombine Facts. Disease List

CarrierMap. Genetic Counseling. Technology TABLE OF. Sample Report CONTENTS. New Offerings. Recombine Facts. Disease List Recombine 2 CarrierMap 4 Genetic Counseling TABLE OF CONTENTS 8 12 14 Technology Sample Report New Offerings 18 Recombine Facts 19 Disease List CARRIERMA ROVIDES COMLETE We help families have healthy children

More information

EVOLVE CARRIER GENETIC SCREENS. Better health for generations to come! Be Proactive. SCREEN TODAY. PROTECT TOMORROW.

EVOLVE CARRIER GENETIC SCREENS. Better health for generations to come! Be Proactive. SCREEN TODAY. PROTECT TOMORROW. EVOLVE CARRIER GENETIC SCREENS Better health for generations to come! Be Proactive. SCREEN TODAY. PROTECT TOMORROW. PROTECT THE HEALTH OF YOUR FUTURE CHILDREN BY KNOWING YOUR GENETIC RISKS, TODAY! Carrier

More information

Family Prep Screen POSITIVE: HIGH REPRODUCTIVE RISK. Cystic Fibrosis

Family Prep Screen POSITIVE: HIGH REPRODUCTIVE RISK. Cystic Fibrosis 123 Main Street Houston, TX 10231 Phone: (800) 555-1212 Fax: (800) 555-1212 FE Sample Type: OG-510 Saliva Date of Collection: 07/08/2014 Date Received: 07/13/2014 Date Tested: 07/13/2014 Indication: No

More information

CARRIER SCREEN - LIST OF DISORDERS

CARRIER SCREEN - LIST OF DISORDERS 1 11-Beta-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 2 17-Beta-Hydroxysteroid deyhdrogenase X deficiency 3 2-Methylbutytyrglycinuria 4 21-hydroxylase deficiency 5 3-Methylcrotonyl-CoA carboxylase

More information

JOHN DOE JANE DOE. Reproductive Risk Summary. Counsyl Test Results Summary

JOHN DOE JANE DOE. Reproductive Risk Summary. Counsyl Test Results Summary Results Recipient University Medical Center 827 Attn: Dr. Paul Smith 123 Main Street Houston, TX 10231 Phone: (800) 555-1212 Fax: (800) 555-1212 NPI: 7834324983 Report Date: 09/09/2013 Female Ethnicity:

More information

23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert

23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert Table of contents Intended Use Important warnings and limitations Test performance User studies Specific test information 23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert For in-vitro

More information

SAMPLE. Carrier Screening Results Report v2.2 Page 1/8

SAMPLE. Carrier Screening Results Report v2.2 Page 1/8 MM480: Pan-Ethnic Carrier Screen - Targeted Mutation Panel Report Prepared For: Patient: Name: Date of Birth: IDs (Internal / External): Reported Gender: Reported Ethnicity: Sample: Sample Collection Date:

More information

Expanded Carrier Screening: What s Best?

Expanded Carrier Screening: What s Best? Expanded Carrier Screening: What s Best? James D Goldberg, MD September 17, 2017 Disclosures James D. Goldberg, M.D. Chief Medical Officer, Counsyl 3 Learning Objectives Guidelines Data Design Practice

More information

Should Universal Carrier Screening be Universal?

Should Universal Carrier Screening be Universal? Should Universal Carrier Screening be Universal? Disclosures Research funding from Natera Mary E Norton MD University of California, San Francisco Antepartum and Intrapartum Management June 15, 2017 Burden

More information

QUESTION. Personal Behavior History. Donor Genetic History. Donor Medical History. Family Medical History PERSONAL BEHAVIOR HISTORY. Never N/A.

QUESTION. Personal Behavior History. Donor Genetic History. Donor Medical History. Family Medical History PERSONAL BEHAVIOR HISTORY. Never N/A. Donor 4576 Medical Profile S Personal Behavior History Donor Genetic History Donor Medical History Family Medical History PERSONAL BEHAVIOR HISTORY Current alcohol use: If yes, oz./week and type of alcohol:

More information

A first step in family planning

A first step in family planning A first step in family planning The Inheritest carrier screen can help your doctor determine if you are at increased risk for having a baby with an inherited disorder, such as cystic fibrosis or spinal

More information

For Your Baby s Health Department of Health

For Your Baby s Health Department of Health Newborn Screening For Your Baby s Health Department of Health Why is my baby tested? To help make sure your baby will be as healthy as possible. The blood test provides important information about your

More information

Metabolic Disorders Screened Overseas but not Screened in Australia Condition Features Inherited Diagnosis Treatment Newborn Screen

Metabolic Disorders Screened Overseas but not Screened in Australia Condition Features Inherited Diagnosis Treatment Newborn Screen Metabolic Disorders ed Overseas but not ed in Australia Biotinidase Deficiency Severe form causes seizures & delay Biotin can prevent complications NZ, USA Tyrosinaemia Type I Coma & death before age 10

More information

GENETIC TESTING AND COUNSELING FOR HERITABLE DISORDERS

GENETIC TESTING AND COUNSELING FOR HERITABLE DISORDERS Status Active Medical and Behavioral Health Policy Section: Laboratory Policy Number: VI-09 Effective Date: 03/17/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members

More information

Related Policies None

Related Policies None Medical Policy MP 2.04.107 BCBSA Ref. Policy: 2.04.107 Last Review: 04/30/2018 Effective Date: 04/30/0218 Section: Medicine Related Policies None DISCLAIMER Our medical policies are designed for informational

More information

Summary of Results CARRIER STATUS DNA INSIGHT. Result: Carrier, Heterozygote. Protected Health Information. Propionic Acidemia

Summary of Results CARRIER STATUS DNA INSIGHT. Result: Carrier, Heterozygote. Protected Health Information. Propionic Acidemia Test Results Reviewed & Approved by: Laboratory Director, Nilesh Dharajiya,.D. SAPLE REPORT CARRIER STATUS DNA INSIGHT PERSONAL DETAILS DOB Jan 1, 19XX ETHNICITY Asian ORDERING HEALTHCARE PROFESSIONAL

More information

Newborn Screening: Focus on Treatment

Newborn Screening: Focus on Treatment Newborn Screening: Focus on Treatment Alan R. Fleischman, M.D. Senior Vice President and Medical Director March of Dimes National Conference of State Legislatures July 21, 2008 Newborn Screening: A Public

More information

The Counsyl Foresight Carrier Screen

The Counsyl Foresight Carrier Screen The Counsyl Foresight Carrier Screen 180 Kimball Way South San Francisco, CA 94080 www.counsyl.com contact@counsyl.com (888) COUNSYL The Counsyl Foresight Carrier Screen - Disease Reference Book 11-beta-hydroxylase-deficient

More information

Evolve FamilyReady Carrier Screen

Evolve FamilyReady Carrier Screen Evolve FamilyReady Carrier Screen Accurate & Comprehensive Expanded Carrier Screen of >200 genes for the most relevant genetic disorders for all ethnicities. Achromatopsia CNGB3 X-linked Adrenoleukodystrophy

More information

Positive Newborn Screens: What do you do next?

Positive Newborn Screens: What do you do next? Positive Newborn Screens: What do you do next? James B. Gibson, MD, Ph.D. Biochemical Geneticist at Specially for Children Clinical Associate Professor of Pediatrics UTHSCSA Carla R. Scott, MD Pediatric

More information

Carrier Screening for Genetic Diseases

Carrier Screening for Genetic Diseases Medical Policy Manual Genetic Testing, Policy No. 81 Carrier Screening for Genetic Diseases Next Review: September 2018 Last Review: December 2017 Effective: January 1, 2018 IMPORTANT REMINDER Medical

More information

[R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH. February October October 1992 (E) September 1995

[R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH. February October October 1992 (E) September 1995 RULES AND REGULATIONS PERTAINING TO THE NEWBORN METABOLIC, ENDOCRINE, AND HEMOGLOBINOPATHY SCREENING PROGRAM AND THE NEWBORN HEARING LOSS SCREENING PROGRAM [R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE

More information

Further expansion of the neonatal screening panel in the Netherlands

Further expansion of the neonatal screening panel in the Netherlands Further expansion of the neonatal screening panel in the Netherlands J.Gerard Loeber APHL-NBSGT, St.Louis (MO), USA 290216 Population Area Newborns 6.01 million 0.35:1 16.8 million 180,693 sq km 4.3:1

More information

Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy

Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy Alan R. Fleischman, M.D. Senior Vice President and Medical Director Chair, Federal Advisory Committee,

More information

PREDICAGEN LLC REPORT

PREDICAGEN LLC REPORT The report below is a scientific interpretation of the DNA variants (referred as RS numbers) to the customer by a third party (for example 23andMe). The report should not be considered exclusive, because

More information

Archived Reports Summary

Archived Reports Summary Archived Reports Summary 1 Archived Reports Summary This summary provides information that may be helpful when viewing your archived reports. The information in this document and in your reports is intended

More information

Utility of Microarrays in Molecular Genetics

Utility of Microarrays in Molecular Genetics Utility of Microarrays in Molecular Genetics Madhuri Hegde, Ph.D., FACMG Associate Professor Senior Director Department of Human Genetics Emory Genetics Laboratory Emory University School of Medicine Atlanta,

More information

Expanded carrier screening for monogenic disorders: where are we now?

Expanded carrier screening for monogenic disorders: where are we now? DOI: 10.1002/pd.5109 SPECIAL TOPIC ISSUE ON ADVANCES IN THE DIAGNOSIS OF SINGLE GENE DISORDERS Expanded carrier screening for monogenic disorders: where are we now? Davit Chokoshvili*, Danya Vears and

More information

ORIGINAL RESEARCH ARTICLE

ORIGINAL RESEARCH ARTICLE American College of Medical Genetics and Genomics Open An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals

More information

Sperm Donor Profile. Asian American Indian African American/Black. Caucasian/White East Indian Latino/Hispanic

Sperm Donor Profile. Asian American Indian African American/Black. Caucasian/White East Indian Latino/Hispanic Sperm Donor Profile This packet is for informational purposes. All the questions have been answered by the donor and are unaltered with exception to the staff impressions, genetic screening results, and

More information

Clinical Policy Title: Genetic testing for maple syrup urine disease

Clinical Policy Title: Genetic testing for maple syrup urine disease Clinical Policy Title: Genetic testing for maple syrup urine disease Clinical Policy Number: 02.01.27 Effective Date: June 1, 2018 Initial Review Date: April 10, 2018 Most Recent Review Date: May 1, 2018

More information

Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015

Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015 Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015 Metabolic birth defects can cause physical problems, mental retardation and, in some cases, death. It is

More information

Most common is the congenital adrenogenital syndrome (AGS) or congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.

Most common is the congenital adrenogenital syndrome (AGS) or congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. Newborn Screening Examination parameters: TSH-neonatal (hypothyreosis), 17-OH progesterone (AGS), galactose (galactosemia), galactose-uridyl transferase (galacto semia), biotinidase (biotinidase ), phenylalanine

More information

Original Policy Date

Original Policy Date MP 2.04.76 Genetic Counseling Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Created Local Policy/ 12:2013 Return to Medical Policy Index Disclaimer

More information

Title: Assessing Recommendations Related To Timeliness of Newborn Screening

Title: Assessing Recommendations Related To Timeliness of Newborn Screening Title: Assessing Recommendations Related To Timeliness of Newborn Screening Purpose: In January 2014, the Secretary s Discretionary Advisory Committee on Heritable Diseases on Newborns and Children (Committee)

More information

BE PROACTIVE. SCREEN TODAY. PROTECT TOMORROW.

BE PROACTIVE. SCREEN TODAY. PROTECT TOMORROW. BE PROACTIVE. SCREEN TODAY. PROTECT TOMORROW. THE LEADER IN FERTILITY & REPRODUCTIVE GENETIC SCREENING EvolveGene was founded by world leaders in preventive and personalized healthcare, with over 25 years

More information

BULGARIAN NATIONAL PLAN. Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD)

BULGARIAN NATIONAL PLAN. Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD) BULGARIAN NATIONAL PLAN FOR RARE DISEASES 2009 2013 Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD) Strategy for rare diseases in Bulgaria Project of National

More information

A. disorders of amino acid metabolism classical phenylketonuria and hyperphenylalaninemia

A. disorders of amino acid metabolism classical phenylketonuria and hyperphenylalaninemia OMIM # FULL NAME A. disorders of amino acid metabolism 1 261600 classical phenylketonuria and hyperphenylalaninemia 2 261640 phenylketonuria due to PTPS deficiency 3 261630 phenylketonuria due to DHPR

More information

Diagnose a broad range of metabolic disorders with a single test, Global MAPS

Diagnose a broad range of metabolic disorders with a single test, Global MAPS PEDIATRIC Assessing or diagnosing a metabolic disorder commonly requires several tests. Global Metabolomic Assisted Pathway Screen, commonly known as Global MAPS, is a unifying test for analyzing hundreds

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Carrier Screening for Genetic Disease File Name: Origination: Last CAP Review: Next CAP Review: Last Review: carrier_screening_for_genetic_disease 12/2013 7/2017 7/2018 7/2017

More information

Medical Policy Preimplantation Genetic Testing

Medical Policy Preimplantation Genetic Testing Medical Policy Preimplantation Genetic Testing Document Number: 004 Commercial* and Connector/ Qualified Health Plans Authorization required X No notification or authorization Not covered * Not all commercial

More information

helpful guide Carrier Testing for Common Genetic Diseases Hemoglobinopathies Cystic Fibrosis Spinal Muscular Atrophy Fragile X

helpful guide Carrier Testing for Common Genetic Diseases Hemoglobinopathies Cystic Fibrosis Spinal Muscular Atrophy Fragile X A helpful guide to Carrier Testing for Common Genetic Diseases Hemoglobinopathies Cystic Fibrosis Spinal Muscular Atrophy Fragile X Joseph Adashek, M.D., FACOG Paul T. Wilkes, M.D., FACOG Van R. Bohman,

More information

Results Recipient Ordering Healthcare Professional Male Details Female Details

Results Recipient Ordering Healthcare Professional Male Details Female Details Results Recipient Ordering Healthcare Professional Male Details Details Report Date /2010 Attn: Jessica Jacobson, MD Counsyl, Inc. 2200 Bridge Parkway, Suite 103 Redwood City, CA 94065 Phone: 1-888-COUNSYL

More information

MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES

MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES NEWBORN SCREENING Protecting your newborn MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES [ 1 ] NEWBORN SCREENING [ 2 ] FREQUENTLY ASKED QUESTIONS [ 4 ] DISORDERS INCLUDED IN NEWBORN SCREENING [ 12 ]

More information

A Guide for Prenatal Educators

A Guide for Prenatal Educators A Guide for Prenatal Educators Why Teach Newborn Screening This booklet is designed to make it easy for you, a prenatal educator, to effectively inform expectant parents about newborn screening. All of

More information

FAMILY PLANNING DOESN T HAVE TO BE ONE OF THEM

FAMILY PLANNING DOESN T HAVE TO BE ONE OF THEM THE ESSENTIAL PANEL There are many unknowns in life. FAMILY PLANNING DOESN T HAVE TO BE ONE OF THEM PLANNING FOR A FAMILY IS A BIG DECISION TAKE STEPS TOWARD A HEALTHY FUTURE WITH NXGEN GENETIC CARRIER

More information

Disclosures. Update on Medical Genetics for Family Practitioners. Objectives. Genetic Testing. Types of Genetic Tests. Dogma of Genetics 08/05/2018

Disclosures. Update on Medical Genetics for Family Practitioners. Objectives. Genetic Testing. Types of Genetic Tests. Dogma of Genetics 08/05/2018 Update on Medical Genetics for Family Practitioners Genetic Testing, Newborn Screening, and Direct to Consumer Testing Sandhya Parkash, MD, FRCPC, FCCMG Maritime Medical Genetics Service, IWK Health Centre

More information

disease carrier status PANEL DETAILS VERSION Risk Details JANE MILLER JOHN MILLER NEGATIVE CARRIER * NEGATIVE MILD CONDITION NEGATIVE

disease carrier status PANEL DETAILS VERSION Risk Details JANE MILLER JOHN MILLER NEGATIVE CARRIER * NEGATIVE MILD CONDITION NEGATIVE 123 Main Street City, CA 10231 Phone: (800) 555-1212 Fax: (800) 555-1212 FE Sample Type: EDTA Blood Date of Collection: 02/06/2014 Date Received: 02/16/2014 Date Tested: 02/16/2014 Indication: Screening

More information

(f) "Birthing center" means any facility that is licensed by the Georgia Department of Community Health as a birthing center;

(f) Birthing center means any facility that is licensed by the Georgia Department of Community Health as a birthing center; Ga. Comp. R. & Regs. r. 511-5-5-.02 Definitions Rule 511-5-5-.02. Definitions (a) "Abnormal test result" is a test result from blood testing or physiologic monitoring that is outside the screening limits

More information

Newborn Screening: Blood Spot Disorders

Newborn Screening: Blood Spot Disorders Newborn Screening: Blood Spot Disorders Arizona s Newborn Screening Program Program Overview Panel of Disorders Disorder Descriptions Program Components Hospitals ADHS Lab ADHS Follow-up ADHS Billing Medical

More information

Reproductive Medicine & Infertility Associates. I. Reproductive Medicine & Infertility Associates (RMIA)

Reproductive Medicine & Infertility Associates. I. Reproductive Medicine & Infertility Associates (RMIA) Reproductive Medicine & Infertility Associates In compliance with the Federal Consumer Credit Protection Act, we wish to notify you of our policies regarding the payment of statements for services rendered

More information

TIMELINESS OF NEWBORN SCREENING: RECOMMENDATIONS FROM ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN

TIMELINESS OF NEWBORN SCREENING: RECOMMENDATIONS FROM ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN TIMELINESS OF NEWBORN SCREENING: RECOMMENDATIONS FROM ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN Susan Tanksley, PhD May 19, 2015 TIMELINESS - BACKGROUND In order to effectively

More information

HA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up

HA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up HA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up Dr. Josephine Chong Clinical Professional Consultant Centre of Inborn Errors

More information

Genomics in Women s Health: Changing the Diagnostic and Therapeutic Paradigm

Genomics in Women s Health: Changing the Diagnostic and Therapeutic Paradigm Genomics in Women s Health: Changing the Diagnostic and Therapeutic Paradigm Lee P. Shulman MD The Anna Ross Lapham Professor in Obstetrics and Gynecology Feinberg School of Medicine of Northwestern University

More information

NEWBORN METABOLIC SCREEN, MINNESOTA

NEWBORN METABOLIC SCREEN, MINNESOTA Lab Dept: Test Name: Chemistry NEWBORN METABOLIC SCREEN, MINNESOTA General Information Lab Order Codes: Synonyms: CPT Codes: Test Includes: PKUN Newborn Screen for Hyopothyroidism, Phenylketonuria (PKU),

More information

NEWBORN SCREENING. health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES

NEWBORN SCREENING. health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES NEWBORN SCREENING health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES Table of Contents NEWBORN SCREENING...1 FREQUENTLY ASKED QUESTIONS...2 DISORDERS INCLUDED IN NEWBORN SCREENING...4

More information

FRAMBU. Resource Centre for Rare Disorders

FRAMBU. Resource Centre for Rare Disorders FRAMBU Resource Centre for Rare Disorders Frambu Resource Centre for Rare Disorders is one of nine centres working with rare disorders in Norway. All nine centres are part of the Norwegian National Advisory

More information

Survey of prenatal testing for genetic disorders in Japan: Recent report

Survey of prenatal testing for genetic disorders in Japan: Recent report doi:10.1111/jog.12948 J. Obstet. Gynaecol. Res. Vol. 42, No. 4: 375 379, April 2016 Survey of prenatal testing for genetic disorders in Japan: Recent report Takahiro Nobuzane 1, Takahiro Yamada 2,KiyonoriMiura

More information

Newborn Screening in Manitoba. Information for Health Care Providers

Newborn Screening in Manitoba. Information for Health Care Providers Newborn Screening in Manitoba Information for Health Care Providers Newborn screening: a healthy start leads to a healthier life Health care professionals have provided newborn screening for phenylketonuria

More information

BE PROACTIVE. SCREEN TODAY. PROTECT TOMORROW.

BE PROACTIVE. SCREEN TODAY. PROTECT TOMORROW. BE PROACTIVE. SCREEN TODAY. PROTECT TOMORROW. THE LEADER IN FERTILITY & REPRODUCTIVE GENETIC SCREENING EvolveGene was founded by world leaders in preventive and personalized health care, with over 25 years

More information

Counsyl Foresight Carrier Screen. Utmost confidence in every result

Counsyl Foresight Carrier Screen. Utmost confidence in every result Counsyl Foresight Carrier Screen Utmost confidence in every result EXTENDING THE BENEFITS OF CARRIER SCREENING Elevate quality of care with expanded carrier screening (ECS) Carrier screening is used to

More information

MEDICAL POLICY SUBJECT: PRENATAL GENETIC TESTING. POLICY NUMBER: CATEGORY: Laboratory Test

MEDICAL POLICY SUBJECT: PRENATAL GENETIC TESTING. POLICY NUMBER: CATEGORY: Laboratory Test MEDICAL POLICY SUBJECT: PRENATAL GENETIC TESTING PAGE: 1 OF: 9 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including

More information

Genetic Testing for Reproductive Carrier Screening and Prenatal Diagnosis

Genetic Testing for Reproductive Carrier Screening and Prenatal Diagnosis Clinical Appropriateness Guidelines Genetic Testing for Reproductive Carrier Screening and Prenatal Diagnosis EFFECTIVE OCTOBER 14, 2017 Appropriate.Safe.Affordable 2017 AIM Specialty Health 2068-1017

More information

Knowledge is power. Plan ahead with GeneAware.

Knowledge is power. Plan ahead with GeneAware. MATERNAL FETAL Many patients may have questions regarding specific genetic disorders that may arise when planning or expecting a baby. That s why Baylor Genetics developed GeneAware, a reproductive carrier

More information

The Compelling Benefits of Routine 2 nd NBS: A Fifteen-Year Review in Washington State. Saving lives with a simple blood spot

The Compelling Benefits of Routine 2 nd NBS: A Fifteen-Year Review in Washington State. Saving lives with a simple blood spot The Compelling Benefits of Routine 2 nd NBS: A Fifteen-Year Review in Washington State Caroline T. Nucup-Villaruz, MD Primary Author NBS Consultant - Disorder FU Santosh Shaunak Co-Author & Presenter Laboratory

More information

Genomics in Primary Care: The Promise of Personalized Medicine

Genomics in Primary Care: The Promise of Personalized Medicine Lehigh Valley Health Network LVHN Scholarly Works Department of Family Medicine Genomics in Primary Care: The Promise of Personalized Medicine Heather B. Fagan MD, MPH Brian Stello MD Lehigh Valley Health

More information

Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis)

Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis) Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis) 1) Argininosuccinic acidemia (ASA) a) Incidence: ~1 in 70,000 b) Deficiency in an enzyme of

More information

CMS will not implement the new tier codes for Medicare/Medicaid claims for calendar year 2012.

CMS will not implement the new tier codes for Medicare/Medicaid claims for calendar year 2012. January 1, 2012 Re: 2012 AMA CPT Code Changes Dear Valued Client: The American Medical Association (AMA) has made Current Procedural Terminology (CPT) code changes to the 2012 edition of the CPT coding

More information

Newborn Screening in Washington State Saving lives with a simple blood spot

Newborn Screening in Washington State Saving lives with a simple blood spot Newborn Screening in Washington State Saving lives with a simple blood spot Ashleigh Ragsdale, MPH Gauri Gupta, MScPH Objectives Newborn Screening Overview Process and Law Completing Collection Cards Video

More information

Inborn Errors of Metabolism (IEM)

Inborn Errors of Metabolism (IEM) Clinical Presentation Inborn Errors of Metabolism (IEM) Click on the following: - Clinical Pearl - link to movie clip - link to picture Investigations Blood Work Urine No Acidosis NH 4 + Metabolic Acidosis

More information

PRE-PREGNANCY CARRIER SCREENING. What is it, how does it work and should future parents consider it?

PRE-PREGNANCY CARRIER SCREENING. What is it, how does it work and should future parents consider it? PRE-PREGNANCY CARRIER SCREENING What is it, how does it work and should future parents consider it? Hi, we re Eugene. We started Eugene to create the healthcare experience we d want for ourselves and our

More information

A Stepwise Approach to Embryo Selection and Implantation Success

A Stepwise Approach to Embryo Selection and Implantation Success Precise Genetic Carrier Screening An Overview A Stepwise Approach to Embryo Selection and Implantation Success Put today s most advanced genetic screening technology to work for you and your family s future.

More information

NEWBORN SCREENING. in Massachusetts: Information for You and Your Baby. University of Massachusetts Medical School

NEWBORN SCREENING. in Massachusetts: Information for You and Your Baby. University of Massachusetts Medical School University of Massachusetts Medical School NEWBORN SCREENING in Massachusetts: Information for You and Your Baby New England Newborn Screening Program Biotech 4, 2nd Floor UMass Medical School 377 Plantation

More information

Assessing the follow-up of BART hemoglobin reported by the Wisconsin Newborn Screening Laboratory

Assessing the follow-up of BART hemoglobin reported by the Wisconsin Newborn Screening Laboratory Assessing the follow-up of BART hemoglobin reported by the Wisconsin Newborn Screening Laboratory Bao Yang MPH Candidate Background The Wisconsin Newborn Screening (NBS) Laboratory screens 70,000 babies

More information

NEWBORN SCREENING. in Massachusetts: Answers for You and Your Baby. University of Massachusetts Medical School

NEWBORN SCREENING. in Massachusetts: Answers for You and Your Baby. University of Massachusetts Medical School University of Massachusetts Medical School NEWBORN SCREENING in Massachusetts: Answers for You and Your Baby New England Newborn Screening Program Biotech 4, 2nd Floor UMass Medical School 377 Plantation

More information

COMMON INHERITED METABOLIC CONDITIONS IN SOUTH AFRICA DIAGNOSING RARE DISEASE IN GENETICALLY UNIQUE AND UNDERSTUDIED POPULATION GROUPS

COMMON INHERITED METABOLIC CONDITIONS IN SOUTH AFRICA DIAGNOSING RARE DISEASE IN GENETICALLY UNIQUE AND UNDERSTUDIED POPULATION GROUPS COMMON INHERITED METABOLIC CONDITIONS IN SOUTH AFRICA DIAGNOSING RARE DISEASE IN GENETICALLY UNIQUE AND UNDERSTUDIED POPULATION GROUPS S MELDAU, G VAN DER WATT INHERITED METABOLIC DISEASES GROUP UCT /

More information

Clinical Approach to Diagnosis of Lysosomal Storage Diseases

Clinical Approach to Diagnosis of Lysosomal Storage Diseases Clinical Approach to Diagnosis of Lysosomal Storage Diseases M. Rohrbach, MD, PhD FMH Pädiatrie und FMH Medizinische Genetik Abteilung Stoffwechsel Universitätskinderklinik Zürich Lysosomal storage disorders

More information

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 12/19/17 SECTION: MEDICINE LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 12/19/17 SECTION: MEDICINE LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE: MEDICAL FOODS Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are

More information

Approach to diagnosis of metabolic diseases

Approach to diagnosis of metabolic diseases Translational Science of Rare Diseases 1 (2016) 3 22 DOI 10.3233/TRD-160001 IOS Press 3 Approach to diagnosis of metabolic diseases Enid Gilbert-Barness a,b and Philip M. Farrell c,d, a Department of Pathology,

More information

CLINICAL MEDICAL POLICY

CLINICAL MEDICAL POLICY Policy Name: Policy Number: Approved By: CLINICAL MEDICAL POLICY Genetic Testing for Cystic Fibrosis MP-006-MD-DE Provider Notice Date: 11/1/2016 Original Effective Date: 12/1/2016 Annual Approval Date:

More information

When users open the application interface, the starting page presents a disclaimer. Upon agreeing to the

When users open the application interface, the starting page presents a disclaimer. Upon agreeing to the Walkthrough of IEMbase When users open the application interface, the starting page presents a disclaimer. Upon agreeing to the disclaimer, users are directed to the main page, which presents a search

More information

GENETIC SCREENING. Prof Dr Karen Sermon, MD, PhD LEARNING OBJECTIVES DISCLOSURE

GENETIC SCREENING. Prof Dr Karen Sermon, MD, PhD LEARNING OBJECTIVES DISCLOSURE GENETIC SCREENING Prof Dr Karen Sermon, MD, PhD LEARNING OBJECTIVES At the conclusion of this presentation, participants should be able to answer the following questions: What is (genetic) screening? Why

More information